8018749

Source:http://linkedlifedata.com/resource/pubmed/id/8018749

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0013018, umls-concept:C0039195, umls-concept:C0376152, umls-concept:C0445356, umls-concept:C1527362, umls-concept:C1709854, umls-concept:C2348205
pubmed:issue	3
pubmed:dateCreated	1994-7-29
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9008950
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Kanamycin Kinase, http://linkedlifedata.com/resource/pubmed/chemical/Neomycin, http://linkedlifedata.com/resource/pubmed/chemical/Phosphotransferases (Alcohol Group..., http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1043-0342
pubmed:author	pubmed-author:BrennerM KMK, pubmed-author:HeslopH EHE, pubmed-author:KranceR ARA, pubmed-author:MoenRR, pubmed-author:RobertsW MWM, pubmed-author:RochesterRR, pubmed-author:RooneyCC, pubmed-author:SixbeyJJ, pubmed-author:SmithC ACA, pubmed-author:TurnerVV
pubmed:issnType	Print
pubmed:volume	5
pubmed:owner	NLM
pubmed:authorsComplete	N
pubmed:pagination	381-97
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:8018749-Adult, pubmed-meshheading:8018749-Biological Markers, pubmed-meshheading:8018749-Bone Marrow Transplantation, pubmed-meshheading:8018749-Cell Line, pubmed-meshheading:8018749-Child, pubmed-meshheading:8018749-Clinical Protocols, pubmed-meshheading:8018749-Cytotoxicity, Immunologic, pubmed-meshheading:8018749-Drug Resistance, pubmed-meshheading:8018749-Female, pubmed-meshheading:8018749-Genetic Vectors, pubmed-meshheading:8018749-Graft vs Host Disease, pubmed-meshheading:8018749-Herpesviridae Infections, pubmed-meshheading:8018749-Herpesvirus 4, Human, pubmed-meshheading:8018749-Humans, pubmed-meshheading:8018749-Immunocompromised Host, pubmed-meshheading:8018749-Incidence, pubmed-meshheading:8018749-Informed Consent, pubmed-meshheading:8018749-Kanamycin Kinase, pubmed-meshheading:8018749-Leukemia, pubmed-meshheading:8018749-Lymphoma, Non-Hodgkin, pubmed-meshheading:8018749-Lymphoproliferative Disorders, pubmed-meshheading:8018749-Male, pubmed-meshheading:8018749-Moloney murine leukemia virus, pubmed-meshheading:8018749-Myelodysplastic Syndromes, pubmed-meshheading:8018749-Neomycin, pubmed-meshheading:8018749-Phosphotransferases (Alcohol Group Acceptor), pubmed-meshheading:8018749-Recombinant Fusion Proteins, pubmed-meshheading:8018749-Safety, pubmed-meshheading:8018749-T-Lymphocytes, Cytotoxic, pubmed-meshheading:8018749-Tissue Donors, pubmed-meshheading:8018749-Transplantation, Homologous, pubmed-meshheading:8018749-Tumor Virus Infections, pubmed-meshheading:8018749-Virus Activation
pubmed:year	1994
pubmed:articleTitle	Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.
pubmed:publicationType	Journal Article, Clinical Trial, Clinical Trial, Phase I